Video Experimental Relacionado

Updated: Jan 8, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

30.3K

Estudio respalda la EMR como criterio de valoración en ensayos de SMD

    Cancer discovery
    |December 17, 2025
    PubMed
    Resumen

    El seguimiento de la enfermedad medible residual (EMR) puede predecir los resultados de supervivencia en la leucemia mieloide aguda (LMA). Este análisis apoya el uso de la EMR como criterio de valoración sustituto en ensayos clínicos para pacientes con LMA.

    Palabras clave:
    enfermedad medible residualleucemia mieloide agudaensayos clínicossupervivenciacriterio de valoración sustituto

    Más Videos Relacionados

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia08:31

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

    Published on: October 17, 2025

    530
    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up09:01

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

    Published on: March 26, 2018

    14.6K

    Videos de Conceptos Relacionados